Explore Cell Therapy
In Explore Cell Therapy, we dig into the latest cell and gene therapy research and best practices to help you advance care for patients with hematologic malignancies and disorders. You’ll hear interviews with well-known and up-and-coming physicians in the hematopoietic stem cell transplantation (HCT) and cell and gene therapy field. You’ll receive insights from the National Marrow Donor Program® and our partners into what it takes to connect patients to the best available therapies. In season 2, we examine practice-changing research and hot topics in HCT and other cellular therapies. You’ll hear conversations with experts who specialize in HCT and at hematology/oncology practices.
Episodes
In this two-part "Explore Cell Therapy" podcast episode, Coleman Lindsley, MD, PhD, and Corey Cutler, MD, MPH, FRCP(C), discuss recent and evolving research supporting the broad benefits of hematopoietic cell transplant (HCT) across all genetic subtypes of myelodysplastic syndrome (MDS), including for patients with high-risk mutations like TP53.
In Part I: Expanding Access to Older Patients, guests explore major advances in transpl...
In this two-part "Explore Cell Therapy" podcast episode, Coleman Lindsley, MD, PhD, and Corey Cutler, MD, MPH, FRCP(C), discuss recent and evolving research supporting the broad benefits of hematopoietic cell transplant (HCT) across all genetic subtypes of myelodysplastic syndrome (MDS), including for patients with high-risk mutations like TP53.
In Part II, experts stress the importance of early consultation to optimize treatment ...
This two-part “Explore Cell Therapy” podcast episode dives into recent research on the benefits and challenges of optimizing donor searches for allogeneic hematopoietic cell transplant (HCT). Joseph Pidala, MD, PhD, Moffitt Cancer Center, and Jason Dehn, MPH, NMDPSM, review crucial findings from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1702 trial to shed light on the pivotal role of search prognosis in help...
This two-part “Explore Cell Therapy” podcast episode dives into recent research on the benefits and challenges of optimizing donor searches for allogeneic hematopoietic cell transplant (HCT). Joseph Pidala, MD, PhD, Moffitt Cancer Center, and Jason Dehn, MPH, NMDPSM, review crucial findings from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1702 trial to shed light on the pivotal role of search prognosis in help...
In this two-part episode, Jonathan Fish, MD, with Cohen Children’s Medical Center and Joanna Pierro, DO, with Staten Island University Hospital discuss the transformative impact of a streamlined referral process to simplify setting up consultations for HCT and cell therapy.
In Part I: Overcoming Barriers through Coordinated Care, guests explore how this simple system created using RedCap software can help overcome logistical barrie...
In this two-part episode, Jonathan Fish, MD, with Cohen Children’s Medical Center and Joanna Pierro, DO, with Staten Island University Hospital discuss the transformative impact of a streamlined referral process to simplify setting up consultations for HCT and cell therapy.
In Part II: Assessing the Impact and Future State, experts stress how early logistical planning and improved communication channels can increase referral volume...
In this two-part episode, Amy DeZern, MD, MHS, with Johns Hopkins and Christin DeStefano, MD, with Uniformed Services University discuss bone marrow transplant as a first-line treatment for severe aplastic anemia, moving beyond the limitations of traditional immunosuppressive therapies for a curative treatment option.
In Part II: Future Research and Care Coordination, experts underscore the critical importance of early referral and...
In this two-part episode, Amy DeZern, MD, MHS, with Johns Hopkins and Christin DeStefano, MD, with Uniformed Services University discuss bone marrow transplant as a first-line treatment for severe aplastic anemia, moving beyond the limitations of traditional immunosuppressive therapies for a curative treatment option.
In Part I: Outcomes and Equity, guests explore the benefits of haploidentical transplant, noting quicker recovery t...
In this two-part episode, Rachel Phelan, MD, MPH, with the Medical College of Wisconsin and Rafeek Yusuf, MD, PhD, with NMDP discuss the latest trends in access and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation according to their recent CIBMTR (Center for International Blood and Marrow Transplant Research) report.
In Part II: Personalization and Future Care, guests highlight the importance of hol...
In this two-part episode, Rachel Phelan, MD, MPH, with the Medical College of Wisconsin and Rafeek Yusuf, MD, PhD, with NMDP discuss the latest trends in access and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation according to their recent CIBMTR (Center for International Blood and Marrow Transplant Research) report.
In Part I: Improvements and Challenges, experts illuminate significant strides in G...
In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.
In Part II: Progressive Research and the Future of Care, guests dive deeper i...
In this two-part episode, Javier Bolaños-Meade, MD, with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Shernan Holtan, MD, with the University of Minnesota discuss advances and innovations in graft-versus-host disease (GVHD) prevention that call for a new standard of care in patients needing allogeneic hematopoietic cell transplantation.
In Part I: PTCy and Improved Outcomes, experts highlight the history of GVHD ...
In this two-part episode, Rachel Salit, MD, with Fred Hutch Cancer Center and Katie Schoeppner, MSW, of NMDP/Be The Match, discuss their recently developed evidence-based guidance for health care providers to assist patients in returning to work after hematopoietic cell transplantation as part of a committee of the American Society for Transplantation and Cellular Therapy (ASTCT).
In Part II: Communication and Resources to Overcome...
In this two-part episode, Rachel Salit, MD, with Fred Hutch Cancer Center and Katie Schoeppner, MSW, of NMDP/Be The Match, discuss their recently developed evidence-based guidance for health care providers to assist patients in returning to work after hematopoietic cell transplantation as part of a committee of the American Society for Transplantation and Cellular Therapy (ASTCT).
In Part I: Guidance Development and Challenges, exp...
In this two-part episode, Zachariah DeFilipp, MD, and Andrew Brunner, MD, with Massachusetts General Hospital discuss their findings on a committee of the American Society for Transplantation and Cellular Therapy (ASTCT) to publish an evidence-based review on guidelines for the use of allogeneic hematopoietic cell transplantation in the management and treatment of myelodysplastic sy...
In this two-part episode, Zachariah DeFilipp, MD, and Andrew Brunner, MD, with Massachusetts General Hospital discuss their findings on a committee of the American Society for Transplantation and Cellular Therapy (ASTCT) to publish an evidence-based review on guidelines for the use of allogeneic hematopoietic cell transplantation in the management and treatment of myelodysplastic sy...
This two-part episode features a panel discussion from Advanced Therapies Week 2023, a conference focused on advancing cell and gene therapy. In a session sponsored by Be The Match BioTherapies® and moderated by Chris McClain, MBA, Heather Stefanski, MD, PhD, Erin Leckrone, MBA, and Gabbi Giammarino, BS, discuss the current state of the cell and gene therapy industry to ramp up clinical trials and expand access to care. In Part 2:...
This two-part episode features a panel discussion from Advanced Therapies Week 2023, a conference focused on advancing cell and gene therapy. In a session sponsored by Be The Match BioTherapies® and moderated by Chris McClain, MBA, Heather Stefanski, MD, PhD, Erin Leckrone, MBA, and Gabbi Giammarino, BS, discuss the current state of the cell and gene therapy industry to ramp up clinical trials and expand access to care. In Part 1:...
In this two-part episode, Stephen Spellman, MBS, and Jeffrey Auletta, MD, with the National Marrow Donor Program®/Be The Match® and the CIBMTR® (Center for International Blood and Marrow Transplantation Research) discuss the current state of the science in finding an optimal donor for all patients in need of allogeneic hematopoietic cell transplantation.
In this two-part episode, Stephen Spellman, MBS, and Jeffrey Auletta, MD, with the National Marrow Donor Program®/Be The Match® and the CIBMTR® (Center for International Blood and Marrow Transplantation Research) discuss the current state of the science in finding an optimal donor for all patients in need of allogeneic hematopoietic cell transplantation.
Popular Podcasts
Daniel Jeremiah of Move the Sticks and Gregg Rosenthal of NFL Daily join forces to break down every team's needs this offseason.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Listen to 'The Bobby Bones Show' by downloading the daily full replay.
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.